Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexmedetomidine as an Intrathecal Adjuvant to Hyperbaric Bupivacaine for Postoperative Analgesia in Patients Undergoing Arthroscopic Anterior Cruciate Ligament Reconstruction Surgeries

NCT06667024 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT06667024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06667024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexmedetomidine as an Intrathecal Adjuvant to Hyperbaric Bupivacaine for Postoperative Analgesia in Patients Undergoing Arthroscopic Anterior Cruciate Ligament Reconstruction Surgeries
Lead sponsor
Tanta University
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2023
Completion date
April 30, 2024
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adjuvant, analgesia, arthroscopic anterior cruciate ligament reconstruction, dexmedetomidine, hyperbaric bupivacaine, intrathecal